Edwards Lifesciences CFO Scott Ullem to step down by mid-2026; successor search underway

Edwards Lifesciences Corp

CFO Scott Ullem informed company on Oct. 30, 2025 of decision to transition by mid-2026.
Company initiating selection process to appoint a new CFO; Ullem will serve in advisory role after appointment.
Plan described as a planned transition to ensure continuity and smooth handoff.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.